1. Home
  2. OSUR vs ABEO Comparison

OSUR vs ABEO Comparison

Compare OSUR & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$2.51

Market Cap

177.2M

Sector

Health Care

ML Signal

HOLD

Logo Abeona Therapeutics Inc.

ABEO

Abeona Therapeutics Inc.

HOLD

Current Price

$5.36

Market Cap

281.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSUR
ABEO
Founded
2000
1974
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.2M
281.0M
IPO Year
1986
1980

Fundamental Metrics

Financial Performance
Metric
OSUR
ABEO
Price
$2.51
$5.36
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$3.00
$18.20
AVG Volume (30 Days)
851.7K
1.8M
Earning Date
11-05-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.29
Revenue
$125,703,000.00
$400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.70
$1,590.36
P/E Ratio
N/A
$4.16
Revenue Growth
N/A
N/A
52 Week Low
$2.08
$3.93
52 Week High
$4.22
$7.54

Technical Indicators

Market Signals
Indicator
OSUR
ABEO
Relative Strength Index (RSI) 49.89 59.34
Support Level $2.42 $4.53
Resistance Level $2.65 $5.61
Average True Range (ATR) 0.12 0.26
MACD 0.04 0.11
Stochastic Oscillator 61.64 78.90

Price Performance

Historical Comparison
OSUR
ABEO

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: